AbCellera Biologics
ABCL
ABCL
146 hedge funds and large institutions have $334M invested in AbCellera Biologics in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 39 reducing their positions, and 17 closing their positions.
Holders
146
Holders Change
+8
Holders Change %
+5.8%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
44
Reduced
39
Closed
17
Calls
$973K
Puts
$1.3M
Net Calls
-$327K
Net Calls Change
+$103K
Top Buyers
1 |
1
Capital World Investors
Los Angeles,
California
|
$23.2M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$5.79M |
3 |
GP
3
Guardian Partners
Toronto,
Canada
|
$5.41M |
4 |
4
Norges Bank
Oslo,
Norway
|
$3.76M |
5 |
5
Millennium Management
New York
|
$4.34M |